InvestorsObserver is giving Kymera Therapeutics Inc (KYMR) an Analyst Rating Rank of 48, meaning KYMR is ranked higher by analysts than 48% of stocks. The average price target for KYMR is $48.461 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating KYMR a Strong Buy today. Find out what this means to you and get the rest of the rankings on KYMR!